Note: Live price is not available for this stock. Showing closing price. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
544529-BOM Stock Analysis
Views
Red Flags
Positive
Not enough talking point with positive stance
Negative
Expensive and at a premium to industry median P/E
Company's earnings are of low quality
Low dividend yield
Neutral
Not enough talking point with neutral stance
Thinly traded (low daily turnover)
The stock is thinly traded with combined (NSE & BSE) daily turnover (21-day average) of 0.182489.
Snapshot
See detailed analysis
544529-BOM Shareholding Pattern
An overview of who owns the company. Click on chart icon to view historical movement.
544529-BOM Bulk, Block & Insider Trades
544529-BOM Dividends, Splits & Bonus
Dividend Events
Capital Change Events
No dividend events found
No capital change events found
Company Profile
Aptus Pharma Limited is an India-based pharmaceutical company. The Company is engaged in developing a range of medicine solutions which include Anti-Infectives, Antacids and PPI, G.I. Medicines, Anti-Allergic and Respiratory Medicine, Nutritional Supplements, Anti-Inflammatory and Pain Management, N... Read More
Key personnel
Mr. Ghanshyam Vinubhai Pansuriya
Chief Executive Officer
Mr. Kapilbhai Hasmukhbhai Chandarana
Chief Financial Officer
Ms. Mohini Hardikbhai Gandhi
Company Secretary, Compliance Officer
Mr. Tejash Maheshchandra HathiD
Managing Director, Executive Director
Mrs. Jyotiben Hasmukhbhai ChandaranaD
Non-Executive Director
Mr. Chetan Shantilal LalsetaD
Non-Executive Director
Dr. Riddhish Natwarlal TannaD
Non-Executive Director
Mr. Vikas Rambhai JobanputraD
Non-Executive Independent Director
View all
Incorporated on
Last Annual
Last Interim
No. of Employees
IPO date
Free Float
Website
Phone no.
Address
Frequently Asked Questions about 544529-BOM
What is the current share price of Aptus Pharma Ltd.?
The current share price of Aptus Pharma Ltd. is ₹ 266.65 as of 25 Feb 2026.
What is the PE ratio of Aptus Pharma Ltd.?
The Price-to-Earnings (PE) ratio of Aptus Pharma Ltd. is 59.01 as of the latest financial data.
What is the ROE and ROCE of Aptus Pharma Ltd.?
Aptus Pharma Ltd. has a Return on Equity (ROE) of 70.99% and a Return on Capital Employed (ROCE) of 37.57% as per the latest financial reports.
What is the market cap of Aptus Pharma Ltd.?
The market capitalization of Aptus Pharma Ltd. stands at ₹ 182.92 Cr.
What is the dividend yield of Aptus Pharma Ltd.?
The dividend yield of Aptus Pharma Ltd. is 0.00% based on the current market price.
What is the RSI of Aptus Pharma Ltd.?
The Relative Strength Index (RSI) of Aptus Pharma Ltd. is 70.99.
What is the FII and DII holding in Aptus Pharma Ltd.?
Foreign Institutional Investors (FII) hold 0.00% and Domestic Institutional Investors (DII) hold 0.00% of Aptus Pharma Ltd. shares.
What sector does Aptus Pharma Ltd. belong to?
Aptus Pharma Ltd. operates in the Healthcare sector.
What is the beta of Aptus Pharma Ltd. stock?
The beta of Aptus Pharma Ltd. stock is -, indicating its volatility relative to the broader market.
